Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Newest Articles
    • Current Issue
    • Methods & Resources
    • Archive
    • Subjects
  • Collections
  • Submit
    • Submit a Manuscript
    • Author Guidelines
    • License, Copyright, Fee
    • FAQ
    • Why Submit
  • About
    • About Us
    • Editors & Staff
    • Board Members
    • Licensing and Reuse
    • Reviewer Guidelines
    • Privacy Policy
    • Advertise
    • Contact Us
    • LSA LLC
  • Alerts
  • Other Publications
    • EMBO Press
    • The EMBO Journal
    • EMBO reports
    • EMBO Molecular Medicine
    • Molecular Systems Biology
    • Rockefeller University Press
    • Journal of Cell Biology
    • Journal of Experimental Medicine
    • Journal of General Physiology
    • Cold Spring Harbor Laboratory Press
    • Genes & Development
    • Genome Research

User menu

  • My alerts

Search

  • Advanced search
Life Science Alliance
  • Other Publications
    • EMBO Press
    • The EMBO Journal
    • EMBO reports
    • EMBO Molecular Medicine
    • Molecular Systems Biology
    • Rockefeller University Press
    • Journal of Cell Biology
    • Journal of Experimental Medicine
    • Journal of General Physiology
    • Cold Spring Harbor Laboratory Press
    • Genes & Development
    • Genome Research
  • My alerts
Life Science Alliance

Advanced Search

  • Home
  • Articles
    • Newest Articles
    • Current Issue
    • Methods & Resources
    • Archive
    • Subjects
  • Collections
  • Submit
    • Submit a Manuscript
    • Author Guidelines
    • License, Copyright, Fee
    • FAQ
    • Why Submit
  • About
    • About Us
    • Editors & Staff
    • Board Members
    • Licensing and Reuse
    • Reviewer Guidelines
    • Privacy Policy
    • Advertise
    • Contact Us
    • LSA LLC
  • Alerts
  • Follow lsa Template on Twitter
Research Article
Source Data
Transparent Process
Open Access

Prion infection, transmission, and cytopathology modeled in a low-biohazard human cell line

Merve Avar, Daniel Heinzer, Nicolas Steinke, Berre Doğançay, Rita Moos, Severine Lugan, Claudia Cosenza, Simone Hornemann, Olivier Andréoletti, View ORCID ProfileAdriano Aguzzi  Correspondence email
Merve Avar
1Institute of Neuropathology, University of Zurich, Zurich, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel Heinzer
1Institute of Neuropathology, University of Zurich, Zurich, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicolas Steinke
1Institute of Neuropathology, University of Zurich, Zurich, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Berre Doğançay
1Institute of Neuropathology, University of Zurich, Zurich, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rita Moos
1Institute of Neuropathology, University of Zurich, Zurich, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Severine Lugan
2UMR INRA/ENVT 1225 IHAP, École Nationale Vétérinaire de Toulouse (ENVT), Toulouse, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Claudia Cosenza
2UMR INRA/ENVT 1225 IHAP, École Nationale Vétérinaire de Toulouse (ENVT), Toulouse, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Simone Hornemann
1Institute of Neuropathology, University of Zurich, Zurich, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Olivier Andréoletti
2UMR INRA/ENVT 1225 IHAP, École Nationale Vétérinaire de Toulouse (ENVT), Toulouse, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adriano Aguzzi
1Institute of Neuropathology, University of Zurich, Zurich, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Adriano Aguzzi
  • For correspondence: adriano.aguzzi@usz.ch
Published 30 June 2020. DOI: 10.26508/lsa.202000814
  • Article
  • Figures & Data
  • Info
  • Metrics
  • Reviewer Comments
  • PDF
Loading

Article Figures & Data

Figures

  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1. Generation and characterization of the ovinized SH-SY5Y cell lines.

    (A) Generation of SH-SY5YΔPRNP cell lines expressing the ovine VRQ PrPC variant and its subsequent infection with the PG127 strain of sheep-derived prions passaged in tg338 mice. HindIII and EcoRI restriction sites were used to clone the ovine PRNP construct. Ticks in the plasmid map correspond to increments of 1,000 base pairs. hSP, human signal peptide (purple); oSP, ovine signal peptide (blue); hovS, monoclonal ovSH-SY5Y; povS, polyclonal ovSH-SY5Y; ovSH-SY5Y, SH-SY5YΔPRNP transfected with a plasmid harboring the sequence for ovine PRNP (ovPRNP). (B) Western blot analysis comparing the expression levels of PrPC in hovS and povS with those in wt SH-SY5Y and in the human cell lines U251-MG and LN229. HovS and povS showed similar PrPC expression levels as U251-MG and LN229, whereas the levels in wt SH-SY5Y were slightly lower. SH-SY5YΔPRNP cells were used as negative control and actin as loading control. The anti-PrP antibody POM2 was used for detection. (C) Confocal imaging to detect cell surface exposed PrPC on hovS and povS. hovS and a subpopulation of povS showed a strong signal for cell surface exposed PrPC, whereas no detectable signal was visible for SH-SY5YΔPRNP. LN229 cells were used as positive control. The anti-PrP antibody POM1 (here and henceforth) was used for detection of PrP.

    Source data are available for this figure.

    Source Data for Figure 1[LSA-2020-00814_Sdata1.tif]

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2. PG127-infected povS and hovS show altered electrophoretic profiles, formation of protease-resistant PrPSc, and enhanced cytopathic effects.

    (A) Western blot analysis of PG127-infected povS and hovS cells indicated a different glycosylation pattern, a shift in the electrophoretic mobility, and partially protease-resistant PrPSc, when compared with noninfectious brain homogenate (NBH) exposed–hovS. Rightmost lanes: NBH- and PG127-infected brain homogenate. PG127-infected SH-SY5YΔPRNP lysate was used as negative control. -PK = non–PK-digested. (A, B) Same samples as in (A), but digested with proteinase K (PK). PrPSc is visible in PG127-infected hovS and the PG127 inoculum. No detectable bands are visible for PG127-infected povS, possibly because of the lower expression of PrPC in these cells. (C) Western blot analysis of pellets and supernatants of cell lysates. The aggregate-enriched pellets of PG127-infected povS and hovS displayed a stronger signal for both total PrP and PrPSc. PG127-infected SH-SY5YΔPRNP, NBH, and the original PG127 inoculate were used as controls. (D) Western blot analysis of pronase E–digested PG127-infected hovS, to investigate the presence of PK-sensitive PrPSc. PG127-infected hovS differed again in their protease resistance pattern from those of the original PG127 inoculum. NBH, non-digested PG127 inoculum and lysate of non-digested PG127-infected hovS were used as controls. (E) ELISpot assay of PG127-infected hovS and povS, visualizing cells harboring PrPSc. Membranes were exposed to decadic dilutions of PG127-infected hovS and povS cell suspensions, PK-digested, and stained with POM1. Positive cells were counted on membranes with 400 cells, as higher cell numbers led to signal saturation in hovS cells. Quantification of positive spots (three replicates) revealed 86% ± 12.5% of infected cells for hovS, and 12% ± 2.7% for povS. No positive spots were detected for NBH-treated hovS and povS and PG127-infected SH-SY5YΔPRNP at 40,000 cells. Data in the graph represent the mean ± SD. (F) Phase-contrast image of PG127-infected hovS showing intracellular accumulation of vacuoles (arrows). Scale bar = 50 μm. (G) PG127-infected hovS showed a slower growth rate than NBH-treated hovS over 180 h in culture. Live images were recorded from n = 6 wells for each condition. ***P = 0.0004 (t test at final time point).

    Source data are available for this figure.

    Source Data for Figure 2[LSA-2020-00814_Sdata2.tif]

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3. Self-propagating activity and transmissibility of PG127-infected hovS and povS.

    (A) The seeding activity of PG127-infected or noninfectious brain homogenate (NBH)–treated hovS, povS, and SH-SY5YΔPRNP lysates was assessed by RT-QuIC (diluted 1:50 and 1:250). PG127-infected hovS, and to a lesser extent, povS cells induced de novo PrP aggregate formation at both dilutions, whereas cell lysates of either NBH-treated or PG127-infected SH-SY5YΔPRNP used as negative controls did not yield a positive signal. Creutzfeldt–Jakob disease (CJD) and non-CJD brain homogenates were used as positive and negative controls for the amplification reaction. Samples were analyzed in quadruplicates. (B) Western blot analysis of serial transmissibility. PG127-infected hovS cell lysates (PG hovS) were used to transmit prion infectivity to fresh hovS cultures. Lysates of undigested and proteinase K–digested hovS exposed to PG127-infected hovS lysates displayed the same electrophoretic profiles as the original lysates. Lysates of hovS exposed to NBH-treated hovS and PG127-infected SH-SY5YΔPRNP cells were used as negative controls. NBH and PG127 inoculum were loaded as additional controls (rightmost lanes). (C) Lysates (20 μl) of PG127-infected hovS and SH-SY5YΔPRNP or NBH-treated hovS were intracerebrally inoculated into tg338 mice. All mice succumbed to disease upon inoculation with PG127-infected hovS lysates with an incubation time of 72 ± 2.5 d. Mice inoculated with control lysates do not show any clinical sign of disease >130 (dpi). n = 6 for each condition. (D) Lysates of PG127-infected hovS (diluted 1:50) were analyzed for propagation efficiency and substrate specificity by PMCA using substrates from various species and of different genotypes (sheep VRQ/VRQ [tg338], sheep ARQ/ARQ [tgARQ], bovine [tgbov], human 129Met [tg650], and human 129V [tg361]). PMCA reactions of the third round were analyzed for PrPSc by Western blotting. Lysates of PG127-infected hovS cells showed positive seeding reactions only with the ovine substrates. NBH-treated hovS and PG127-infected SH-SY5YΔPRNP were used as negative controls and PG127, BSE, and sCJD prions amplified with the respective substrates as positive controls. Reference: PG127 inoculum used to control for signal intensity and band shifts. One representative data set from three experiments is shown.

    Source data are available for this figure.

    Source Data for Figure 3[LSA-2020-00814_Sdata3.tif]

PreviousNext
Back to top
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Life Science Alliance.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Prion infection, transmission, and cytopathology modeled in a low-biohazard human cell line
(Your Name) has sent you a message from Life Science Alliance
(Your Name) thought you would like to see the Life Science Alliance web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Prion infection and cytopathology modeled in human cells
Merve Avar, Daniel Heinzer, Nicolas Steinke, Berre Doğançay, Rita Moos, Severine Lugan, Claudia Cosenza, Simone Hornemann, Olivier Andréoletti, Adriano Aguzzi
Life Science Alliance Jun 2020, 3 (8) e202000814; DOI: 10.26508/lsa.202000814

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Prion infection and cytopathology modeled in human cells
Merve Avar, Daniel Heinzer, Nicolas Steinke, Berre Doğançay, Rita Moos, Severine Lugan, Claudia Cosenza, Simone Hornemann, Olivier Andréoletti, Adriano Aguzzi
Life Science Alliance Jun 2020, 3 (8) e202000814; DOI: 10.26508/lsa.202000814
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
Issue Cover

In this Issue

Volume 3, No. 8
August 2020
  • Table of Contents
  • Cover (PDF)
  • About the Cover
  • Masthead (PDF)
Advertisement

Jump to section

  • Article
    • Abstract
    • Introduction
    • Results
    • Discussion
    • Materials and Methods
    • Acknowledgements
    • References
  • Figures & Data
  • Info
  • Metrics
  • Reviewer Comments
  • PDF

Subjects

  • Neuroscience
  • Methods & Resources

Related Articles

  • No related articles found.

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Risk variants in regulatory elements
  • UBQLN2-dependent alterations
  • Activity profiling an E3 ligase in a developmental disorder
Show more Research Article

Similar Articles

EMBO Press LogoRockefeller University Press LogoCold Spring Harbor Logo

Content

  • Home
  • Newest Articles
  • Current Issue
  • Archive
  • Subject Collections

For Authors

  • Submit a Manuscript
  • Author Guidelines
  • License, copyright, Fee

Other Services

  • Alerts
  • Twitter
  • RSS Feeds

More Information

  • Editors & Staff
  • Reviewer Guidelines
  • Feedback
  • Licensing and Reuse
  • Privacy Policy

ISSN: 2575-1077
© 2022 Life Science Alliance LLC

Life Science Alliance is registered as a trademark in the U.S. Patent and Trade Mark Office and in the European Union Intellectual Property Office.